Related Experiment Videos
Neuroendocrine differentiation in human prostatic carcinoma
1Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, NY 14642.
Human Pathology
|March 1, 1992
Summary
Prostate neuroendocrine cells regulate gland function and differentiation. Their differentiation in prostate cancer often indicates a poorer prognosis and potential resistance to hormonal therapy.
Area of Science:
- Urology
- Endocrinology
- Oncology
Background:
- Endocrine-paracrine (APUD, neuroendocrine) cells are present in prostatic epithelium.
- These cells exhibit diverse morphology and produce various peptides like serotonin and somatostatin.
- They play regulatory roles in prostate growth, differentiation, and secretory processes.
Purpose of the Study:
- To review the literature on neuroendocrine differentiation in the prostate.
- To discuss the implications of neuroendocrine differentiation in prostatic carcinoma.
- To explore the role of hormone production in cancer screening and monitoring.
Main Methods:
- Literature review of neuroendocrine differentiation in prostatic carcinoma.
- Analysis of different forms of neuroendocrine differentiation (small cell carcinoma, carcinoid tumors, adenocarcinoma with focal differentiation).
- Discussion of prognostic factors and therapeutic resistance associated with neuroendocrine differentiation.
Main Results:
- Neuroendocrine differentiation is common in prostate cancer, often focal in adenocarcinomas.
- It is associated with a poorer prognosis and may correlate with tumor grade.
- Neoplastic neuroendocrine cells might be resistant to hormonal therapy.
Conclusions:
- Neuroendocrine differentiation is a significant feature in prostatic carcinoma with prognostic implications.
- Hormone production by these cells could be useful for cancer detection and follow-up.
- Further research is needed on the role of neuroendocrine cells in prostate carcinogenesis and tumor growth.